Checkpoint Therapeutics Inc (NASDAQ:CKPT) Sellers Decreased By 22% Their Shorts As Of Apr 16, 2018

April 16, 2018 - By Alice Reed

Checkpoint Therapeutics Inc (NASDAQ:CKPT) recorded a decrease of 22% in shorted shares. FINRA issued shorted shares of CKPT’s total 7,800 shares. Previously was reported down change of 22% from 10,000 shares. Former CKPT’s position will need 0 days to restore. It has 43,900 average volume. 0.06% is Checkpoint Therapeutics Inc float short.

The stock decreased 4.87% or $0.2118 during the last trading session, reaching $4.1382.Checkpoint Therapeutics, Inc. has volume of 1,673 shares. Since April 16, 2017 CKPT has 0.00% and is . CKPT underperformed by 11.55% the S&P 500.

Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers.The firm is worth $132.49 million. The Company’s pipeline consists of human, immuno-oncology, and checkpoint inhibitor antibodies that target programmed death-ligand 1; glucocorticoid-induced TNFR-related protein; and carbonic anhydrase IX.Last it reported negative earnings. The firm is also developing three oral, small-molecule, targeted anti-cancer agents that inhibit epidermal growth-factor receptor mutations, the bromodomain and extra-terminal protein BRD4, and poly polymerase.

Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: